Navigation Links
Zometa [Novartis Drug] For Treatment Of Paget’s Diseas

Results of the clinical study carried out by Professor Ian Reed and his team from the University of Auckland in New Zealand has found that the drug Zometa manufactured by Novartis treats Paget’s disease// far better than the drug Actonel produced by Procter and Gamble.

Paget's disease is a condition in which the bones breaks or becomes weak faster than the normal and the new bone replacement does not replace it properly. Paget’s disease occurs in about 2 percent of people above the age of 60. In serious conditions Paget’s disease can be very painful and can lead to bone fractures.

Zometa [Novartis drug], halted bone deterioration and abnormal bone growth for at least a year in about 95 percent of patients with Paget's disease. Dr. Paul Miller, collaborator of test centers at 75 medical centers in 10 countries said, "Zometa produced a "higher response, faster response and a longer duration of remission" in tests against daily treatments of Procter & Gamble Pharmaceutical's Actonel”. The results of the study which was published in The New England Journal of Medicine found that Zometa led to six months of improvement in 96 percent of 176 people tested.

Though, the drug Zometa can produce mild side effects, flu-like symptoms such as mild fever and muscle aches these symptoms disappear after four days, said the researchers, led by Ian Reed of the University of Auckland in New Zealand. Zoledronic acid is approved by Food and Drug Administration as a treatment for Paget's disease in Canada and 27 European countries and the drug is under review by the U.S
'"/>




Page: 1

Related medicine news :

1. Novartis files application with FDA for Zometa
2. Advances in Treatment of Cataracts
3. Recommendations for Treatment of Blood Pressue
4. Treatment for Menieres disease
5. Treatment for pre-menstrual syndrome is ineffective
6. Better Treatment for obesity
7. Gene Treatment for Heart Disease
8. More People Seeking Treatment for Depression
9. Focused Treatment For Childhood Cancer
10. Inadequate Drug Treatment For Youth
11. FDA Approves New surgery Treatment for Farsightedness
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 28, 2017 , ... Revolution for Truth ... Congress to protect parental rights and civil liberties, and to restore transparency within ... The demonstration coincides with a press conference taking place Friday morning calling on ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... of all holidays (IBT World Travel Trends Report). As travelers visit both urban ... range in temperatures, and prolonged sun exposure. In response, the outdoor industry has ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... announced today the launch of a free, public-facing tool for analyzing the costs ... was developed to provide comparative information to patients, providers, insurers and pharmaceutical companies ...
(Date:3/28/2017)... ... ... WHO: , Dr. Paul Thomas; Dr. Brian Hooker; Dr. Judy Mikovits; Dr. Jennifer ... speak to the press on behalf of over 200 doctors, scientists, and scientific organizations ... , WHERE: , Zenger Room, National Press Club, 529 14th Street NW, 13th ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... laboratory instruments are critical to ensuring high-quality results and maintaining GMP and USP ... of Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017 /PRNewswire/ - StarFish Medical, ... development firm, announced today that it has merged with ... medical device industrial design and productization organization.  The resulting ... North America with easier east coast ... the design, engineering, regulatory, and manufacturing process. ...
(Date:3/28/2017)... BOSTON , March 28, 2017 /PRNewswire/ ... today announced a partnership with premium news ... allows pharmaceutical companies to extract key insights from ... text mining technology. The Linguamatics I2E ... top 20 global pharmaceutical companies. The Linguamatics-Dow Jones ...
(Date:3/28/2017)... , March 28, 2017 Emosis SAS, ... new business entity, Emosis Ltd, headquartered in Tel Aviv ... novel assays complementing the mother company existing technology platform and test ... sales development of Emosis kits. ... This strategic move starts building Emosis international footprint. Emosis ...
Breaking Medicine Technology: